Randomized trial of the efficacy of adjuvant chemotherapy for colon cancer with combination therapy incorporating the oral pyrimidine 1-hexylcarbamoyl-5- fluorouracil

Langenbeck's Archives of Surgery

Volumn 391, Issue 4, 2006, Pages 330-337

  Watanabe, Masahiko ^a   Kodaira, Susumu ^b   Takahashi, Takashi ^c   Tominaga, Takeshi ^c   Hojo, Keuchi ^d   Kato, Tomoyuki ^e   Kunitomo, Kazufumi ^f   Isomoto, Hiroharu ^g   Ohashi, Yasuo ^h   Yasutomi, Masayuki ⁱ  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f UNIVERSITY OF TOKUSHIMA   (Japan)

^g KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h UNIVERSITY OF TOKYO   (Japan)

ⁱ KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adjuvant chemotherapy; Colon cancer; HCFU; Oral pyrimidine; Randomized trial

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARMOFUR; FLUOROURACIL; MITOMYCIN C;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DYSESTHESIA; FEMALE; HEMATURIA; HUMAN; IRON DEFICIENCY ANEMIA; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NAUSEA AND VOMITING; NEUTROPENIA; POLLAKISURIA; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SKIN DISEASE; THROMBOCYTOPENIA; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FLUOROURACIL; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33748056110     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-006-0044-6     Document Type: Article

References (29)

1. Macdonald JS, Astrow AB (2001) Adjuvant therapy of colon cancer. Semin Oncol 28:30-40
2. Wils J, O'Dwyer P, Labianca R (2001) Adjuvant treatment of colorectal cancer at the turn of the century: European and US perspectives. Ann Oncol 12:13-22
3. Ragnhammar P, Hafstrom L, Nygren P (2001) A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 40:282-308
4. Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, McCormack GW, Gerstner JB, Krook JE, Malliard J (1989) Surgical adjuvant therapy of large bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 7:1447-1456
5. Wolmark N, Rockette H, Mamounas E, Jone J, Wieand S, Wickerham DL, Bear HD, Atkins JN, Dimitrov NV, Glass AG, Fisher ER, Fisher B (1999) Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from national surgical adjuvant breast and bowel project C-04. J Clin Oncol 17:3553-3559
6. Sakamoto J, Hamada C, Kodaira S, Nakazato H, Ohashi Y (1999) Adjuvant therapy with oral fluoropyrimidines as main chemotherapeutic agents after curative resection for colorectal cancer: individual patients data meta-analysis of randomized trials. Jpn J Clin Oncol 29:78-86
7. Miyauchi M, Yamamoto N, Matsumoto M, Shishikura T, Hyakutake K (2000) Comparative clinical study on 5-FU concentrations for oral HCFU and i.v. 5-FU. Gan To Kagaku Ryoho 27:1011-1014
8. Koyama Y (1981) 1-Hexylcarbamoyl-5-fluorouracil (HCFU) - a masked 5-fluorinated pyrimidine. Cancer Treat Rev 8:147-156
9. Sugimachi K, Maehara Y, Ogawa M, Kakegawa T, Tomita M, Akiyoshi T (1996) Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection. Cancer 77:36-43
10. Ito K, Yamaguchi A, Miura K, Kato T, Koike A, Takagi H (1996) Prospective adjuvant therapy with mitomycin C and carmofur (HCFU) for colorectal cancer, 10-year follow-up: Tokai HCFU Study Group, the first study for colorectal cancer. J Surg Oncol 62:4-9
11. Ito K, Yamaguchi A, Miura K, Kato T, Baba S, Matsumoto S, Ishii M, Takagi H (1996) Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: five-year follow-up. Tokai HCFU Study Group - third study on colorectal cancer. J Surg Oncol 63:107-111
12. Sakamoto J, Kodaira S, Hamada C, Ito K, Maehara Y, Takagi H, Sugimachi K, Nakazato H, Ohashi Y, Meta-analysis Group of the Japanese Society of Strategies for Cancer Research and Therapy (2001) An individual patient data meta-analysis of long supported adjuvant chemotherapy with oral carmofur in patients with curatively resected colorectal cancer. Oncol Rep 8:697-703
13. Yasutomi M, Takahashi T, Kodaira S, Hojo K, Kato T, Ogawa M, Ichihashi H, Tominaga T, Tamada R, Kunii Y, Kikuchi K (1997) Prospective controlled study on the usefulness of Carmofur as a postoperative adjuvant chemotherapy for colorectal cancer. Gan To Kagaku Ryoho 24:1953-1960
14. Watanabe M, Nishida O, Kunii Y, Koraira S, Takahashi T, Tominaga T, Hojo K, Kato T, Niimoto M, Kunitomo K, Isomoto H, Ohashi Y, Yasutomi M (2004) Randomized controlled trial on the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexyl-carbamoyl-5-fluorouracil and uracil/tegafur. Int J Clin Oncol 9:98-106
15. Japanese Society for Cancer of the Colon and Rectum (1985) Japanese classification of colorectal carcinoma, 4th edn. Kanehara Ltd., Tokyo
16. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
17. Ito K, Yamaguchi A, Miura K, Kato K, Baba S, Matsumoto S, Ishii M, Takagi H (2000) Effect of oral adjuvant therapy with Carmofur (HCFU) for distant metastasis of colorectal cancer. Int J Clin Oncol 5:29-35
18. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators (1995) Efficacy of adjuvant fluorouracil and folinic acid in colorectal cancer. Lancet 345:939-944
19. Zaniboni A (1997) Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survival. J Clin Oncol 15:2432-2441
20. Meropol NJ, Sonnichsen DS, Birkhofer MJ (1997) Oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer. Oncology 11:22-25
21. Douillard JY, Hoff PM, Skillings JR, Eisenberg P, Davidson N, Harper P, Vincent MD, Lembersky BC, Thompson S, Maniero A, Benner SE (2002) Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20:3605-3616
22. Carmichael J, Popiela T, Radstone D, Falk S, Borner M, Oza A, Skovsgaard T, Munier S, Martin C (2002) Randomised comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20:3617-3627
23. Hoff PM, Ansari R, Batist G, Cox J, Kocha W, Kuperminc M, Maroun J, Walde D, Weaver C, Harrison E, Burger HU, Osterwalder B, Wong AO, Wong R (2001) Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 19:2282-2292
24. Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, Bugat R, Findlay M, Frings S, Jahn M, McKendrick J, Osterwalder B, Perez-Manga G, Rosso R, Rougier P, Schmiegel WH, Seitz JF, Thompson P, Vieitez JM, Weitzel C, Harper P, Xeloda Colorectal Cancer Study Group (2001) Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19:4097-4106
25. Rougier P, Van Cutsem E, Bajetta E, Niederle N, Possinger K, Labianca R, Navarro M, Morant R, Bleiberg H, Wils J, Awad L, Herait P, Jacques C (1998) Randomized trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 352:1407-1412
26. Douillard J, Cunningham D, Roth A, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M, Gruia G, Awad L, Rougier P (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicenter randomized trial. Lancet 355:1041-1047
27. Van Cutsem E, Pozzo C, Starkhammar H, Dirix L, Terzoli E, Cognetti F, Humblet Y, Garufi C, Filez L, Gruia G, Cote C, Barone C (1998) A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colon cancer. Ann Oncol 9:1199-1204
28. Levi F, Zidani R, Misset JL (1997) Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chemotherapy. Lancet 350:681-686
29. De Gramont A, Banzi M, Navarro M, Tabernero J, Hickish T, Bridgewater J, Rivera F, Figer A, Fountzilas G, Andre T (2003) Oxaliplatin/5-FU/LV in adjuvant colon cancer: results of the international randomized mosaic trial. Proc Am Soc Clin Oncol 22:253(Abstr 1015)